Fulcrum Therapeutics
$16.179876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$16.17
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.23 (-1.40%) Today
$0.00 (0.00%) As of 5:08 PM EST after-hours
Why Robinhood?
You can buy or sell FULC and other stocks, options, ETFs, and crypto commission-free!
About FULC
Fulcrum Therapeutics, Inc. Common Stock, also called Fulcrum Therapeutics, is a clinical-stage biopharmaceutical company. Read More It develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015 and is headquartered in Cambridge, MA.
Employees
57
Headquarters
Cambridge, Massachusetts
Founded
2015
Market Cap
442.55M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
67.78K
High Today
$17.18
Low Today
$15.91
Open Price
$16.48
Volume
55.50K
52 Week High
$22.96
52 Week Low
$4.37
Collections
FULC Earnings
-$9.21
-$6.14
-$3.07
$0.00
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 30, Pre-Market
People Also Bought
Sorrento Therapeutics
12,148
$2.30
-3.77%Fitbit
267,952
$6.42
-0.47%Myovant Sciences
5,523
$10.30
-7.79%Viking Therapeutics
39,327
$6.57
-3.81%Hexo
166,386
$1.26
-3.82%Clovis Oncology
5,151
$8.00
-19.35%Stoke Therapeutics
1,124
$24.50
-1.96%Arvinas
411
$48.00
-3.90%BridgeBio Pharma
704
$31.94
-3.94%Cortexyme
611
$54.38
-2.26%RAPT Therapeutics
1,092
$28.19
-1.09%Cyclerion Therapeutics
1,906